National Interventional Pain Management - Qualified Clinical Data Registry Receives CMS Approval
The American Society of Interventional Pain Physicians (ASIPP) with great enthusiasm announces today the approval of the National Interventional Pain Management - Qualified Clinical Data Registry (NIPM-QCDR) by the Centers for Medicare and Medicaid Services (CMS) for the 2017 reporting year. NIPM-QCDR will assist interventional pain physicians fulfill requirements of the Merit-based Incentive Payment System (MIPS) under the CMS Quality Payment Program (QPP).
The CMS-approved NIPM-QCDR will capture and analyze data that are clinically relevant and appropriate for interventional pain physicians. Physicians who participate in NIPM-QCDR will be able to understand and adjust their 2017 performance to improve patient outcomes and optimize future reimbursements under the CMS QPP. They will also be better prepared for CMS quality reporting in future years when penalties and incentives get even larger.
"Approval by CMS of the NIPM-QCDR is one of the most consequential achievements for the interventional pain management community. It is a historic achievement with approval of 70 percent of the proposed measures during the first year. The registry ensures the high quality of evidence based interventional pain management, benefitting interventional pain physicians in a multitude of ways, allowing them to avoid penalties, potentially gain large incentives, and maintain registries for multiple interventional pain management techniques. It will ultimately improve the quality of care with fewer hassles," said Dr. Laxmaiah Manchikanti, Chairman of the Board of ASIPP.
NIPM-QCDR will include general MIPS measures, as well as nine specialty-specific measures developed by ASIPP that are relevant, clinically appropriate, and meaningful to interventional pain physicians and their patients. To read all nine non-MIPS measures, click here.
Participate in NIPM-QCDR
For more information or to sign up for NIPM-QCDR, follow the link below, or register to attend an upcoming "Measure What Matters" webinar on Thursday, June 8 or Thursday, June 15.
Register for the upcoming webinar
Sign up for the NIPM-QCDR or request more information
|
|
Board Certification Testing Available in June in Orlando, FL
Make plans now to take one of the following exams during the June 16 – 18th course in Orlando, FL.
We will be offering the following exams
and
Written and Oral Exams will be held on Saturday, June 17. Hand-on lab exam will be Sunday 18th
|
|
2017 ASIPP Washington Legislative trip Set for Sept 12-13, 2017
At no other time in the history of the American Society of Interventional Pain Physicians has it been more important for you, as members, to get involved in our advocacy efforts. Our specialty has been gravely affected by drastic and severe coverage cuts. These cuts so radical, they have hurt more than just our bottom lines; some practices and surgery centers have been forced to close their doors.
The election of President Trump and his appointment of Representative Tom Price as Health and Human Services Secretary and Seema Verma to head the Centers for Medicare and Medicaid Services have given us some hope and an opportunity to achieve some of our goals, and possibly reverse these cuts retroactively and reinstate the previous reimbursement or even improve reimbursement for 2018.
Now is our chance! Let your voices be heard!
We have scheduled a legislative conference September 12 and 13. To participate in this conference, you must to be in Washington on Tuesday, September 12 in order to attend the preparation session. Wednesday, September 13, we will head to Capitol Hill to hear speeches and meet with Senators and Representatives. Some appointments may continue through Thursday. If you would like to leave on Wednesday, please do not plan on leaving before 6 pm.
Each member is expected to visit two senators and one member of Congress for a total of three visits.
ASIPP will be booking a block of rooms for those who choose to attend. You will be responsible for travel expenses.
Please let us know as soon as possible if you will be attending so that we can begin making the appointments. Contact Kasi Stunson kstunson@asipp.org.
|
|
Long-Term Opioids May Not Help in Polyneuropathy
Patients had worse functional outcomes than controls; some became dependent
Long-term opioid therapy in patients with polyneuropathy appears to increase the risk of adverse outcomes without benefiting functional status, researchers said.
Data from a retrospective, population-based cohort study showed that 18.8% of 2,892 patients with polyneuropathy received opioids continuously for at least 90 days compared to 5.4% of 14,435 controls. They were also more likely to rely on gait aids and have difficulty climbing stairs (adjusted HR 1.7) and experience depression (adjusted HR 1.53), opioid dependence (aHR 2.85), and opioid overdose (aHR 5.12) compared to controls, Christopher J. Klein, MD, of the Mayo Clinic in Rochester, Minn, and colleagues reported online in JAMA Neurology.
MedPage Today
|
|
Most consumers would leave a healthcare provider that was struck by ransomware
About 68 percent of U.S. consumers would consider leaving their healthcare provider if it was negatively impacted by ransomware, according to a survey of 5,000 U.S. consumers conducted by end-point security vendor Carbon Black. The survey was conducted, Carbon Black said, to gauge the public’s perception of ransomware and expectations they place on organizations to keep their data safe following the recent WannaCry ransomware outbreak.
Approximately 7 out of 10 consumers in the survey trust their financial institutions and healthcare providers to keep data safe; only 52 percent trust retailers.
Healthcare IT News
|
|
Sues Five Drug Firms, Saying They Fueled Opioid Crisis
Ohio’s attorney general said the state is suing five drugmakers, alleging they fueled the opioid crisis by misrepresenting the addictive risks of their painkillers.
The lawsuit targets Purdue Pharma LP, Endo Health Solutions, Janssen Pharmaceuticals, Cephalon and Allergan PLC, a spokeswoman for Attorney General Mike DeWine said. The companies couldn’t immediately be reached to comment.
Wall Street Journal
Access to this article may be limited.
|
|
Ketamine for Pain Management, Treatment of Depression
Ketamine may alleviate depression, pain, and adverse effects associated with opioid treatment, and may thus represent an attractive adjunct therapy for pain management, according to a novel population analysis recently published in Scientific Reports.1
Nearly half of all patients with depression taking conventional antidepressants discontinue their treatment prematurely.2 Researchers have sought alternatives to standard antidepressants, for which therapeutic effects are delayed by 2 to 10 weeks.3
Cohen IV, Makunts T, Atayee R, Abagyan R. Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. Sci Rep 2017;7:1450.
|
|
Sciatic Nerve Block Plus Femoral Nerve Block May Provide Superior Pain Relief After Total Knee Arthroplasty
Pain relief after total knee arthroplasty (TKA) may be greater when femoral nerve block (FNB) is combined with sciatic nerve block (SNB) than when it is combined with local infiltration analgesia (LIA).1
While previous research indicates that FNB plus SNB provides superior pain management for TKA, adding SNB to FNB may increase the occurrence of adverse effects such as weakness of the quadriceps, leading to postoperative falls.2
“Furthermore, there is a risk of peripheral nerve injury, which has an incidence of 0.024% in patients who receive SNB.3 Sciatic nerve injury is also a common complication following TKA and its incidence is 1.3 to 2.2%,” the researchers noted.4,5“Therefore,
LIA combined with FNB was suggested to achieve comparable pain control.”
|
|
Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine.
We would like to invite you to submit research case reports, brief commentaries and reviews to
Interventional Pain Management Reports
Journal. Your article will be published
‘FREE’ of charge.
Led by Editor in Chief: Kenneth Candido, MD, Chairman and Professor, Department of Anesthesiology , Advocate Illinois Masonic Medical Center in Chicago, IPM Reports focuses on the promotion of excellence in the practice of interventional pain management and clinical research.
Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of
Pain Physician.
Interventional Pain Management Reports
Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.
The benefits of publishing in an open access journal that has a corresponding print edition journal are:
- Your article will have the potential to obtain more citations.
- Your article will be peer-reviewed and published faster than other journals.
- Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.
- Open Access journals are FREE to view, download and to print.
So submit today your:
Case Reports
Technical Reports
Editorials
Short Perspectives
Click
HERE to read the Instructions for Authors for article submission
Click
HERE to submit a manuscript
|
|
OHSIPP Meeting
August 25-27, 2017
The Ohio Society of Interventional Pain Physicians (OHSIPP) has set the dates for its 2017 meeting.
Dates are Friday Aug 25 thru Sunday Aug 27, 2017. The meeting will be held in Cincinnati at the Westin Hotel, 21 E 5th St , at Fountain Square .
Contact Michelle Byers for more information MichelleHByers@gmail.com
|
|
|
|
|
|
|